Gamma knife radiosurgery for pituitary tumours

Area of Science:

• Neurosurgery
• Radiation Oncology
• Endocrinology

Background:

• Stereotactic radiosurgery (SRS) using the Gamma Knife delivers focused radiation to pituitary tumors.
• It is primarily used for recurrent pituitary tumors after surgery or as a primary treatment for medically unsuitable patients.
• The technique aims to minimize radiation exposure to surrounding healthy brain tissue.

Purpose of the Study:

• To evaluate the efficacy and safety of Gamma Knife radiosurgery for pituitary tumors.
• To compare its outcomes with conventional fractionated radiotherapy.
• To assess the risks and benefits for patients with varying tumor characteristics and treatment histories.

Main Methods:

• Single-session focused radiation delivery using a cobalt-60 source.
• Precise targeting of pituitary tumors while sparing adjacent normal brain tissue.
• Dosimetric control to limit radiation to critical structures like the optic chiasm (<10 Gy).

Main Results:

• Gamma Knife SRS is effective in treating pituitary tumors, including those with lateral invasion into the cavernous sinus.
• It shows faster remission rates for secretory tumors compared to fractionated radiotherapy.
• Major risks, such as radiation damage to visual pathways, can be mitigated through dose limitation.

Conclusions:

• Gamma Knife SRS is a safe and effective treatment modality for pituitary tumors, offering advantages over conventional radiotherapy.
• It provides a viable alternative for patients unsuitable for surgery.
• The risk of secondary brain tumors and neuropsychiatric effects appears reduced compared to traditional radiation methods.